Ezetrol will be the first "cholesterol absorption inhibitor" for hyperlipidemia

Ezetrol will be the first "cholesterol absorption inhibitor" for hyperlipidemia.

It just got approved in the U.S. under the name Zetia. It's now being considered in Canada.

It's different than other drugs that block cholesterol absorption.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote